12:00 AM
 | 
Feb 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

Alkermes, Elan deal

Elan raised $169.7 million through the sale of its remaining 7.8 million shares of Alkermes in an offering underwritten by...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >